Terms: = Ovarian cancer AND PBX1, P40424, 5087
11 results:
1. Interplay between ceRNA and Epigenetic Control of microRNA: Modelling Approaches with Application to the Role of Estrogen in ovarian cancer.
Huang TW; Cheng FHC; Yan CS; Chuang YM; Cho CH; Lai HC; Shieh SF; Chan MWY; Tsai JC
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216394
[TBL] [Abstract] [Full Text] [Related]
2. Disease-inducing potential of two leukemic cell lines in a xenografting model.
Manavella DD; Herraiz S; Soares M; Buigues A; Pellicer A; Donnez J; Díaz-García C; Dolmans MM
J Assist Reprod Genet; 2021 Jun; 38(6):1589-1600. PubMed ID: 33786735
[TBL] [Abstract] [Full Text] [Related]
3. A novel c-Kit/phospho-prohibitin axis enhances ovarian cancer stemness and chemoresistance via Notch3-pbx1 and β-catenin-ABCG2 signaling.
Fang CH; Lin YT; Liang CM; Liang SM
J Biomed Sci; 2020 Mar; 27(1):42. PubMed ID: 32169072
[TBL] [Abstract] [Full Text] [Related]
4. CA125 over-release behavior following a 75-g oral glucose test as a predictive biomarker of multidrug resistance in patients with ovarian cancer.
He Y; Gu Z; Zhu Q; Chen M; He C; Huang Y; Li Q; Di W
Int J Cancer; 2019 Sep; 145(6):1690-1700. PubMed ID: 30807642
[TBL] [Abstract] [Full Text] [Related]
5. ovarian cancer Chemoresistance Relies on the Stem Cell Reprogramming Factor pbx1.
Jung JG; Shih IM; Park JT; Gerry E; Kim TH; Ayhan A; Handschuh K; Davidson B; Fader AN; Selleri L; Wang TL
Cancer Res; 2016 Nov; 76(21):6351-6361. PubMed ID: 27590741
[TBL] [Abstract] [Full Text] [Related]
6. Myoepithelioma of the ovary: first reported case.
Houghton OP; Sumathi VP; Loyson SA; McCluggage WG
Int J Gynecol Pathol; 2014 Mar; 33(2):191-6. PubMed ID: 24487475
[TBL] [Abstract] [Full Text] [Related]
7. Prevalence and incidence of comorbidities in elderly women with ovarian cancer.
Chia VM; O'Malley CD; Danese MD; Lindquist KJ; Gleeson ML; Kelsh MA; Griffiths RI
Gynecol Oncol; 2013 May; 129(2):346-52. PubMed ID: 23422502
[TBL] [Abstract] [Full Text] [Related]
8. Identification of pbx1 target genes in cancer cells by global mapping of pbx1 binding sites.
Thiaville MM; Stoeck A; Chen L; Wu RC; Magnani L; Oidtman J; Shih IeM; Lupien M; Wang TL
PLoS One; 2012; 7(5):e36054. PubMed ID: 22567123
[TBL] [Abstract] [Full Text] [Related]
9. Identification of pbx1, a potential oncogene, as a Notch3 target gene in ovarian cancer.
Park JT; Shih IeM; Wang TL
Cancer Res; 2008 Nov; 68(21):8852-60. PubMed ID: 18974129
[TBL] [Abstract] [Full Text] [Related]
10. A newly identified RET proto-oncogene polymorphism is found in a high number of endocrine tumor patients.
Gartner W; Mineva I; Daneva T; Baumgartner-Parzer S; Niederle B; Vierhapper H; Weissel M; Wagner L
Hum Genet; 2005 Jul; 117(2-3):143-53. PubMed ID: 15841388
[TBL] [Abstract] [Full Text] [Related]
11. Endoscann cell sampling for cytological assessment of endometrial pathology.
Hansen PK; Junge J; Roed H; Fischer-Rasmussen W; Højgaard K
Acta Obstet Gynecol Scand; 1986; 65(5):397-9. PubMed ID: 3776481
[TBL] [Abstract] [Full Text] [Related]
